| Brand name |
Gilenya
|
|---|---|
| المخاطر |
Safety information about contraindication in pregnant women and in women of childbearing potential not using effective contraception, Communication on progressive multifocal leukoencephalopathy (PML) , Hemophagocytic syndrome (HPS), Cardiovascular, Adverse Events after the First Dose, Slow heart rate and irregular heartbeat, Instructions for proper use, Updated recommendations to minimize the risk of drug-induced liver injury (DILI). |
| Safety messages for healthcare practitioners |
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
Thu 25 Jun 2026
Beta version
Official Saudi government website domains end with gov.sa
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Government websites use the protocol. HTTPS for encryption and security.
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.